Skip to main content
See every side of every news story
Published loading...Updated

White House Launches TrumpRx: What It Is And Who Benefits

TrumpRx.gov offers 43 brand-name drugs with varying discounts, aiming to empower consumers despite most insured Americans paying lower prices, health care CEOs said.

  • Last week, the Trump administration launched TrumpRx.gov, a government direct-to-consumer platform listing 43 discounted prescription medicines showcased at a White House event on Feb. 5, 2026.
  • Seeking to bypass pharmacy benefit managers, the administration secured commitments from 17 major pharmaceutical companies producing discounts from 33% to 93%.
  • A four‑week supply of Wegovy injection pens is priced at $199 for the first two months and $349 after that on TrumpRx.gov, while Gonal‑F appears at $252 with purchases routed via printable coupons to participating pharmacies.
  • Uninsured and high‑deductible patients stand to gain most from TrumpRx, as discounts mainly help those without coverage or using fertility and GLP‑1 drugs, while many prices exceed what 92% of the U.S. population with insurance pay and purchases don’t count toward health insurers and plan deductibles.
  • CEOs and industry observers gave mixed reactions, with Wendy Barnes, CEO of GoodRx, praising expanded reach while raising questions about BlinkRx ties to Donald Trump Jr.
Insights by Ground AI

12 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 90% of the sources are Center
90% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

GovCon Wire broke the news in on Monday, February 9, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal